Sarepta Therapeutics Inc

Common Name
Sarepta Therapeutics
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
1,372
Ticker
SRPT
Exchange
NASDAQ/NGS
Description
Sarepta Therapeutics Inc. is a biopharmaceutical company dedicated to developing precision genetic medicine for the treatment of rare neuromuscular diseases. With an emphasis on RNA-targeted therapeut...

Sarepta Therapeutics Waste Data Preview

In 2023, Sarepta Therapeutics conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2024202320222021 - 2017
Total Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Waste Recovered
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Hazardous Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Non-Hazardous Waste Disposed
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.

Insights into Sarepta Therapeutics’s Generation of Hazardous and Non-Hazardous Waste

In 2023, Sarepta Therapeutics generated a total of 214 metric tonnes of waste.

Of this amount, 11.21% of Sarepta Therapeutics's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 88.79% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.

Sarepta Therapeutics’s Hazardous vs Non-Hazardous Waste Over Time

20222023055110165220tonnes
  • Total Non-Hazardous Waste Generated
  • Total Hazardous Waste Generated

How Sarepta Therapeutics reduced the environmental impact of its waste?

Since 2023, Sarepta Therapeutics's total waste generation has increased by 43.62%, which may reflect expanding operations, weaker material efficiency, or insufficient waste reduction efforts.

Since 2023, Sarepta Therapeutics's hazardous waste generation has increased by 19.36%, indicating a potential rise in the use of harmful materials, process inefficiencies, or limited hazardous waste reduction strategies..

Overall, Sarepta Therapeutics has seen a recent increase in both total waste and hazardous waste, which may indicate growing operational pressures or insufficient controls on harmful materials.

Want Full Access to Sarepta Therapeutics's Waste Management Dataset?
Sign Up